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ABSTRACT (241 words) 33 
Objective: We aimed at estimating the seroprevalence of Toxoplasma gondii infection in older adults 34 
living in Central Africa and investigating its association with dementia using data from the 35 
Epidemiology of Dementia in Central Africa (EPIDEMCA) programme. 36 
Methods: A cross-sectional multicentre population-based study was carried out among participants 37 
aged 73 (±7) years on average, living in rural and urban areas of the Central African Republic and the 38 
Republic of Congo between November 2011 and December 2012. Blood samples were collected from 39 
each consenting participant. The detection of anti-T.gondii immunoglobulin G antibodies was 40 
performed in 2014 in France using a commercially available ELISA kit. Participants were interviewed 41 
using a standardized questionnaire including sociodemographic characteristics. DSM-IV criteria were 42 
required for a diagnosis of dementia. Multivariate binary logistic regression models were used to 43 
estimate the association between toxoplasmosis infection and dementia. 44 
Results: Among 1,662 participants, the seroprevalence of toxoplasmosis was 63.0% (95% confidence 45 
interval (CI): 60.7-65.3) overall, 66.6% (95%CI: 63.4-69.8) in Central African Republic and 59.4% 46 
(95%CI: 56.1-62.7) in the Republic of Congo. In multivariate analyses, toxoplasmosis status was 47 
significantly associated with increasing age (p=0.006), Republic of Congo (p=0.002), urban area 48 
(p=0.001) and previous occupation (p=0.002). No associations between dementia and toxoplasmosis 49 
status or anti- T.gondii IgG titres were found. 50 
Conclusion: T.gondii infection was not associated with dementia among older adults in Central Africa. 51 
Our findings are consistent with previous studies and add to the knowledge on the relationship 52 
between T.gondii infection and neurological disorders. 53 
 54 
 55 
Keywords: Dementia, Alzheimer’s Disease, Toxoplasma gondii, seroprevalence, older adults, sub-56 
Saharan Africa 57 
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INTRODUCTION (3,103 words) 58 
Globally, 25-30% of individuals are infected with Toxoplasma gondii (T.gondii) (1;2) with disparities 59 
across regions, depending on geographical and socio-economic conditions (1;2). Previous studies 60 
estimated at around 40% the prevalence of T.gondii infection in general population in the Republic of 61 
Congo (ROC) and in the Central African Republic (CAR) (3;4;4). T.gondii infection seroprevalence is 62 
primarily studied in population at risk for developing acute toxoplasmosis such as women of 63 
childbearing age and immuno-compromised patients. Although the risk of being infected with T.gondii 64 
increases with age (5), its prevalence among older adults and the effect of age on anti-T.gondii 65 
antibody titre evolution remain largely unknown. 66 
During a primary T.gondii infection, the invasive tachyzoite stages circulate in the blood, invade the 67 
various organs, cross the blood-brain barrier and establish themselves in the brain cells probably as 68 
soon as the end of the first week of infection. This acute toxoplasmosis phase lasts a few weeks. It is 69 
usually asymptomatic, but can also present as a benign disease with lymphadenopathies, fever and 70 
asthenia. Beyond this acute phase, the invasive tachyzoite stages are no longer present, and the chronic 71 
stage of infection is characterized by the presence of latent toxoplasmic cysts in the tissues, and more 72 
particularly the central nervous system. This chronic stage is assumed to persist throughout life 73 
without inducing any symptoms in immunocompetent patients (1). 74 
Dementia is a neurodegenerative disease characterized by progressive decline in cognitive functions, 75 
progressive functional impairment, and behavioural and psychological symptoms (6). Alzheimer’s 76 
disease, characterized by two core cerebral lesions (β amyloid plaques and neurofibrillary tangles), is 77 
the most common cause of dementia among older people. Lewy Body disease, frontotemporal lobar 78 
degeneration, and vascular disease, are other common causes of dementia, differing in 79 
pathophysiology (7). However, mixed pathologies are much more common than ‘pure’ forms of 80 
dementia (8). Dementia has a significant impact on those affected, their families and society, with 81 
considerable costs worldwide (9). Demographic ageing worldwide is expected to lead to a dramatic 82 
increase in the number of cases, and African countries are not spared by this phenomenon (10). The 83 
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prevalence of dementia in adults aged 65 years and older was recently estimated between 6.4% and 84 
8.5% in CAR and between 5.7% and 6.7% in ROC (11;12). 85 
Literature studying the association between latent T.gondii infection and neurological or psychiatric 86 
disorders is growing (13-17). Chronic infection compromised goal-directed behaviour (18), affected 87 
several aspects of memory (19;20), led to a decline in visual motor coordination, coding ability and 88 
short term memory (21), and to a more rapid decline in executive function and cognitive decline 89 
among older adults (21). Cognitive dysfunctions were attributed to cysts’ location in the brain (22;23), 90 
to the immune response in chronically infected patients (24), or to a change in cerebral metabolism 91 
(23;25). A chronic infection accompanied by an increase in interferon γ (IFN-γ) production decreases 92 
the tryptophan pool affecting kynurenic acid and serotonin levels. Moreover, T.gondii infection 93 
increases the activity of the tyrosine hydrolase that in turn releases dopamine. The increase in 94 
kynurenic acid and dopamine levels along with the decrease in serotonin level were associated with 95 
cognitive dysfunctions in rodents (23;26;27) and in humans (28). T.gondii infection was however 96 
shown to decrease β-amyloid plaque deposition in the cortex and hippocampus suggesting positive 97 
effects of T.gondii infection on the pathogenesis and progression of Alzheimer’s disease (AD) in mice 98 
(29-31). In humans, case-control studies dedicated to T.gondii infection and dementia reported 99 
contradictory results (32-35). Most studies focused on the Alzheimer’s subtype (32;33;35). Two 100 
studies found no association between AD and toxoplamosis infection in the USA (33) and in Iran (32) 101 
whilst the third one in Turkey suggested that toxoplasma infection may be involved in the 102 
pathogenetic mechanisms of AD (35). The only study investigating dementia (all subtypes combined), 103 
in Egypt, showed that toxoplasma positive participants had an increased likelihood of having 104 
dementia, regardless of their ApoE genotype (34). To our knowledge, no study has been conducted in 105 
sub-Saharan African countries yet, where both dementia and T. gondii epidemiology may present 106 
particular aspects. 107 
We aimed first at estimating the seroprevalence of T.gondii infection among older adults in Central 108 
Africa; secondly, at investigating the association between T.gondii infection and dementia, within the 109 
 6 
 
Epidemiology of Dementia in Central Africa (EPIDEMCA) programme, a large population-based 110 
study. 111 
 112 
METHODS 113 
Participants 114 
Our study population consisted of participants included in the EPIDEMCA programme, a multicentre 115 
cross-sectional population-based study conducted in CAR and ROC between November 2011 and 116 
December 2012. The detailed methodology is described in an open access publication (36). In essence, 117 
participants aged 65 years and older who had lived in the study area for at least six months were 118 
included. The study areas included the capitals of CAR (Bangui) and ROC (Brazzaville), and two rural 119 
areas (Nola in CAR and Gamboma in ROC). The sample size was calculated a priori with the aim of 120 
estimating dementia prevalence, and was then rounded at 500 in each study site. In absence of detailed 121 
census, the participants’ selection in urban areas was carried out using a proportional random sampling 122 
(to represent Bangui and Brazzaville’s diverse populations) while a door-to-door approach was 123 
preferred due to logistic and financial constraints in rural areas. Response rates varied between 93 and 124 
97% across sites, with the only exclusion criteria being refusal or the presence of severe disease with 125 
short-term high risk of death.   126 
Approvals were obtained from the ethical committee supervised by the Ministry of Public Health in 127 
CAR, the Comité d’Éthique de la Recherche en Sciences de Santé in ROC, and an ethical review 128 
board from the Comité de Protection des Personnes du Sud-Ouest et d’Outre-Mer 4 in France. All 129 
participants and/or their families gave informed consent prior to inclusion in the study. Written 130 
consent was obtained when feasible. Consent was obtained by thumbprint for illiterate people. 131 
Serological analysis 132 
Each consenting participant had 20 mL of blood collected into two polypropylene EDTA tubes by a 133 
dedicated nurse. Whole fresh blood samples were centrifuged and aliquoted within few hours to avoid 134 
degradation due to high temperatures and then frozen at -20°C or -80°C in the nearest laboratory. 135 
Plasma aliquots were stored at the Pasteur Institute of Bangui in CAR and the National Laboratory of 136 
 7 
 
Public Health in Brazzaville in ROC before dry-ice shipping to the University of Limoges where 137 
plasma samples were kept stored at -80°C until analysed. In 2014, the detection of anti-T.gondii 138 
immunoglobulin G (IgG) was done using the VIDAS TOXO IgG II test (Biomérieux, France), 139 
according to the manufacturer's instructions. This test is validated for detection of anti-T.gondii IgG in 140 
plasma. Results were reported in International Units per millilitre (IU/mL). Samples with anti-T.gondii 141 
IgG <4 IU/mL were considered as seronegative. A sample was considered as positive when the titre 142 
was equal or greater than 8 IU/mL. Samples with titres ≥300 UI/mL were diluted in the negative 143 
control included with the VIDAS TOXO IgG II test until titres could be determined. Titres comprised 144 
between 4 IU/mL and 8 IU/mL were considered as equivocal and further analysed by VIDAS TOXO 145 
competition (Biomérieux, France), which better correlated with low titres of the usual reference test, 146 
namely dye-test. Samples with indexes below 1.6 were considered as seropositive according to the 147 
manufacturer's instructions. The T.gondii positive group included all participants that were positive 148 
either with VIDAS Toxo IgG II or with VIDAS Toxo Competition assay.  149 
Dementia assessment 150 
Dementia was assessed following a two-stage process. First, cognitive screening was performed using 151 
the Community Screening Interview for Dementia (CSI-D) (37) adapted, back-translated and pretested 152 
in the local languages (Sango in CAR, Lari, Lingala, and Kituba in ROC). Every participant obtaining 153 
a poor performance on the CSI-D cognitive tests (COGSCORE ≤24.5) was suspected of having 154 
cognitive impairment and referred for neurological assessment. During the second phase which was 155 
conducted at the hospital 3-14 weeks later, further psychometric tests were conducted, including the 156 
Free and Cued Selective Reminding Test (38), Zazzo’s cancellation task (39) and Isaac’s Set Test of 157 
verbal fluency (40). Neurologists performed clinical examination, recorded history of stroke and 158 
presence of depressive disorders, and assessed orientation skills and daily activities. Dementia was 159 
diagnosed according to the DSM-IV criteria (6). An experienced neurologist (JFD) reviewed all 160 
medical records and cognitive test performances in order to reach a consensus. 161 
Statistical analysis 162 
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Sociodemographic data included age, sex, marital status (married, never 163 
married/widowed/divorced/separated), education (no education, at least primary school), occupation 164 
(farmer/breeder/fisher vs. other), country (CAR, ROC) and area (urban, rural). Age was ascertained 165 
from official documents, using historical events or from an informant if previous methods were 166 
unsuccessful. All variables were collected during the first phase in all participants. 167 
Study population characteristics were described in terms of means with corresponding standard 168 
deviations for age, median with its inter-quartiles range (IQR) for antibody titres and cognitive scores, 169 
and percentages for all categorical variables. Prevalence of toxoplasmosis was presented with its 95% 170 
confidence interval (CI). Comparisons were carried out between countries using the Chi-square test 171 
and Kruskal-Wallis test when appropriate. The correlation between the anti-IgG titre and age was 172 
tested using the Spearman test. 173 
Factors associated with T.gondii infection were examined using logistic regression models. All factors 174 
associated with T.gondii infection and dementia at p<0.20 in univariate analysis were included in 175 
multivariate logistic regression model. The variable selection was carried out using a backward 176 
stepwise approach in which variables considered to be a confounder (odds ratio’s variation above 177 
15%) were kept in the model. The association between toxoplasmosis and dementia was first analysed 178 
in unadjusted logistic regression model and then in a model adjusted for age, sex, country, area and 179 
education.  180 
In a sensitivity analysis, we ran the fully-adjusted logistic regression model with quintiles of anti-IgG 181 
titres as dependent variable instead of toxoplasmosis status.   182 
The level of significance was fixed at 0.05 for all analyses. Statistical analyses were carried-out using 183 
Stata version 10.1 for Windows (StataCorp, College Station, TX). 184 
 185 
RESULTS 186 
Characteristics of the EPIDEMCA participants 187 
Among 2,002 participants included in the EPIDEMCA study, 340 participants were excluded because 188 
they did not have blood samples due to refusals (n=176), impossible blood withdrawal (n=35), poor 189 
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health conditions (n=34), absence on the day of blood collections (n=9), and non-exploitable samples 190 
(n=86). A total of 1,662 participants were therefore analysed (Figure 1). 191 
General socio-demographic characteristics are shown in Table 1. Participants were 73.1 (±6.6) years 192 
on average and ROC participants were older and less likely living as a couple than those from CAR. 193 
Seroprevalence of Toxoplasma infection 194 
Of the 1,662 individuals, 1,047 were found to be positive for anti-T.gondii IgG antibodies, i.e. a 195 
seroprevalence of 63.0% (95%CI: 60.7-65.3). The seroprevalence was lower in ROC than in CAR 196 
(p=0.002) and as a whole, lower in rural areas than urban areas (57.3% [95%CI: 53.9-60.7] vs. 68.5% 197 
[95%CI:65.4-71.6]; p<0.001) (Figure 2). In both country, the seroprevalence was significantly 198 
associated with areas (p<0.001) but the urban-rural gradient was inversed.  199 
In bivariate analyses, T.gondii infection was significantly associated with increasing age in 5-year 200 
bands, country, rural areas, no education, and previous occupation. In multivariate analysis, T.gondii 201 
infection remained significantly associated with country, area and previous occupation (Table 2).  202 
Median anti-T.gondii IgG titre was 32 (IQR 120) IU/mL (min-max: 0-15 000), 22 (105) IU/mL in 203 
ROC and 47 (128) IU/mL in CAR (p<0.001). A total of 99 participants (6.0%) had anti-T.gondii IgG 204 
titre>300 IU/mL, 44 (5.3%) in CAR and 55 (6.0%) in ROC (p=0.28), and 48 (2.9%) had a titre above 205 
1000 IU/mL, 21 (2.5%) in CAR and 27 (3.2%) in ROC (p=0.40). No correlation between the anti-IgG 206 
titre and age was found (r=0.044; p=0.07). 207 
Association between T.gondii infection and dementia 208 
A total of 379 participants were excluded because cognitive status could not be determined for 276 of 209 
them (including 174 lost of follow up or missing) and 102 participants were diagnosed with MCI, 210 
resulting in an analytical sample size of 1,386 participants (Figure 1). Among them, 100 (7.2%) had 211 
dementia. Table 3 presents the socio-economic and clinical characteristics of participants with and 212 
without dementia. The T.gondii infection seroprevalence did not differ significantly based on the 213 
cognitive status: 64.0% (95%CI: 54.6-73.4) in participants with dementia versus 63.4% (95%CI: 60.7-214 
66.0) in those without dementia (p=0.94). In the unadjusted and adjusted models, no association was 215 
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shown between T.gondii seroprevalence and dementia (respectively OR=1.0 (95%CI: 0.7-1.6) and 216 
adjusted OR=1.0 (95%CI: 0.6-1.6)).  217 
In a sensitivity analysis, we replaced the Toxoplasma infection status by quintiles of anti-IgG titre 218 
(Figure 3). No association was observed in both unadjusted (p=0.13) or adjusted models (p=0.36). 219 
 220 
DISCUSSION 221 
To our knowledge, this large population-based study is the first study to investigate the prevalence of 222 
T.gondii infection in older native African adults and the first study to examine its relationship with 223 
dementia in the Central African context. We found a high prevalence of T.gondii infection in older 224 
people regardless of areas (urban or rural) and countries. However we did not find any association 225 
between T.gondii and dementia.  226 
In African tropical countries, such as CAR and ROC, a high prevalence of toxoplasmosis is usually 227 
observed due to the low sanitary conditions, with poor or inexistent water treatment (1;2). In these 228 
conditions, soil, food and water contaminated with oocysts increase the risk of T.gondii infection.  229 
The higher seroprevalence observed in CAR may be partly explained by the lower socioeconomic 230 
status in CAR compared to ROC (41). T.gondii infection was described as associated with poverty in 231 
different countries due to poor hygienic and sanitary conditions (42-44). 232 
In our study, the seroprevalence was significantly higher in urban areas than in rural areas as a whole, 233 
but differences were observed at the country level. In CAR, the seroprevalence was higher in rural 234 
area than in urban area while, in ROC, an inverse rural-urban gradient was observed. In ROC, a more 235 
westernised lifestyle of Brazzaville inhabitants could lead to a more frequent meat intake than in 236 
Gamboma where meat is more expensive. Seroprevalence was also lower in people who worked or are 237 
working in farms, fisheries or with livestock. People performing better paid occupations may thus 238 
have access to a diet richer in fruits, vegetables and meat that may be contaminated with parasite. 239 
Unfortunately, soil exposure was not collected and data about food consumption were limited.  240 
Heterogeneity in populations (women of childbearing age vs. older people) and design (case-control 241 
vs. cross-sectional survey) limits the comparison of our findings with other studies.   242 
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Surprisingly, we found a relatively large number of older adults with high antibody titres. Although 243 
studies on the evolution of the T.gondii serology in older populations are scarce (45), it is generally 244 
accepted that antibody titre decreases with age and are maintained at a low level over lifetime after an 245 
initial primary infection (46). Lifetime persistence of anti-T.gondii IgG results from continuous 246 
immune system stimulation by long-lasting tissue cysts. The usual decrease in antibody titres in older 247 
adults is hypothesized to be linked to the development of immunosenescence (47). Several hypotheses 248 
may explain the relatively high proportion of elevated titres in older people in our study: i) a primary 249 
infection during the sample collection. The detection of IgM antibodies could have confirmed this 250 
hypothesis, but it was not tested here due to financial constraints; ii) a reinfection by a different 251 
Toxoplasma strain that would have resulted in an increase in IgG titres. Indeed, clinical observations 252 
have shown that an immune response against a chronic infection does not prevent reinfection of 253 
immunocompetent individuals with a strain different that the one responsible for the primary infection 254 
(48). This hypothesis cannot be ruled out in our study since different genotypes have been identified in 255 
Central Africa (49-51). The immunosenescence or a T-cell exhaustion during a chronic infection (52)  256 
could facilitate the process of re-infection. iii) a non-specific and chronic immune stimulation due to 257 
different infectious agents (malaria, and other parasitic and viral diseases); iv) a genetic background 258 
leading to a higher humoral immune response in African population. Indeed, a high proportion 259 
(40.8%) of high levels of anti-T.gondii IgG (>400 IU/mL) was also reported in CAR in younger 260 
people (53). 261 
Previous studies that examined the association between T.gondii chronic infection and Alzheimer’s 262 
disease (AD) or dementia reported conflicting results (32-35). Our findings are contradictory with the 263 
ones of the only study assessing T.gondii infection as a correlate of dementia, carried out in a much 264 
younger population in Egypt (34). Different methodologies, including participant recruitment and 265 
statistical analyses, may explain these discrepancies. Another explanation may be the influence of the 266 
T.gondii strain on chronic brain infection in immunocompetent patients. In in-vitro cell culture 267 
systems, different immune responses or neurotransmitter expression were observed in human nervous 268 
cell infected by diverse T.gondii strains (54-56). In humans, a serotyping study suggested that 269 
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serological pattern consistent with Type I strain in mothers was more susceptible to be associated with 270 
psychosis in offspring (57). More recently, in a murine model of AD, only mice infected with a type II 271 
strain of T.gondii, a major lineage that predominates in Europe and North America, were protected 272 
against deposition of amyloid beta, a marker of AD, despite both type II and type III strains 273 
establishing a chronic CNS infection and inflammatory response (29). Mice infected with an 274 
attenuated type I strain that does not persist in mouse brain were not protected against amyloid beta 275 
deposition. Transposing data from animal models to human populations is particularly delicate as not 276 
all dementia subtypes share the same pathophysiological process and knowledge of the strains 277 
circulating in different countries is still incomplete (51;58;59). We however can reasonably think that 278 
our participants were infected by African strains, which share some genetic similarities with type I 279 
strains. Our results suggest that strains circulating in sub-Saharan Africa have no association with 280 
dementia. 281 
The main strengths of our study are the use of a large, multicentre population-based design, the high 282 
number of participants with blood sample and a rigorous methodological method for establishing 283 
dementia diagnosis. However, a few limitations must be acknowledged. We were not able to analyse 284 
dementia sub-types, notably Alzheimer’s disease, due to low frequencies. Additionally, we lack data 285 
that might influence our results such as timing of initial infection, interactions with other infectious 286 
diseases, and host genetic factors, as well as wealth or income which are potential confounders. Due to 287 
the study design, we are not able to rule out that earlier deaths due to T.gondii seropositivity obscured 288 
the association with dementia.  289 
This large multicentre population-based study showed a high prevalence of T.gondii infection in older 290 
adults in Central Africa, with disparities in two neighbouring but different countries and areas related 291 
to socioeconomic and sanitary conditions. We failed to show any association between T.gondii chronic 292 
infection and dementia but future investigations should consider the association with Alzheimer’s 293 
disease and Mild Cognitive Impairment. Another perspective would be to evaluate associated 294 
infectious agents as done for other neurological conditions (60). 295 
 296 
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Table 1: Sociodemographic characteristics of participants based on country (n=1,662), EPIDEMCA, 472 
2011-2012 473 
474 
 Total CAR ROC p 
Sample, n 1662 827 835  
Age (years), n (%)    0.010 
 65-69 608 (36.6) 329 (39.8) 279 (33.4)  
 70-74 427 (25.7) 216 (26.1) 211 (25.3)  
 75-79 327 (19.7) 153 (18.5) 174 (20.8)  
 80 + 300 (18.1) 129 (15.6) 171 (20.5)  
Sex, n (%)    0.583 
 Males 644 (38.8) 315 (38.1) 329 (39.4)  
 Females 1018 (61.3) 512 (61.9) 506 (60.6)  
Area, n (%)    0.085 
 Urban 847 (51.0) 439 (53.1) 408 (48.9)  
 Rural 815 (49.0) 388 (46.9) 427 (51.1)  
Education, n (%)    0.812 
 No education 1148 (69.2) 569 (68.9) 579 (69.4)  
 At least primary school 512 (30.8) 257 (31.1) 255 (30.6)  
 Missing values 2 1 1  
Marital status, n (%)    0.017 
 Living as a couple 616 (37.1) 283 (45.9) 333 (39.9)  
 Single, widow, separated/divorced 1044 (62.9) 543 (65.7) 501 (60.1)  
 Missing values 2 1 1  
Previous occupation, n (%)    0.790 
 Farmer, breeder, fisherman 817 (49.3) 409 (49.6) 408 (48.9)  
 Others 842 (50.8) 416 (50.4) 426 (51.1)  
 Missing values 3 2 1  
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Table 2: Factors associated with Toxoplasma seroprevalence (n=1662), EPIDEMCA, 2011-2012 
  
  Univariate analysis 
Initial multivariate 
model 
Final multivariate 
model 
  Not infected 
n(%) 
Infected 
n(%) 
OR (95%CI) p OR (95%CI) p OR (95%CI) p 
Age (years)    0.029  0.003  0.006 
 65-69 237 (38.5) 371 (35.4) 1  1  1  
 70-74 174 (28.3) 253 (24.2) 0.9 (0.7-1.2)  1.0 (0.7-1.2)  0.9 (0.7-1.2)  
 75-79 108 (17.6) 219 (20.9) 1.3 (1.0-1.7)  1.4 (1.1-1.9)  1.4 (1.0-1.8)  
 80+ 96 (15.6) 204 (19.5) 1.4 (1.0-1.8)  1.5 (1.1-2.1)  1.5 (1.1-2.0)  
Sex    0.111  0.631   
 Males 223 (36.3) 421 (40.2) 1  1    
 Females 392 (63.7) 626 (59.8) 0.8 (0.7-1.0)  0.9 (0.7-1.2)    
Country    0.002  0.002  0.002 
 CAR 276 (44.9) 551 (52.6) 1  1  1  
 ROC 339 (55.1) 496 (47.4) 0.7 (0.6-0.9)  0.7 (0.6-0.9)  0.7 (0.6-0.9)  
Area    0.001    0.001 
 Rural 348 (56.6) 467 (44.6) 1  1  1  
 Urban 267 (43.4) 580 (55.4) 1.6 (1.3-2.0)  1.4 (1.1-1.8)  1.4 (1.2-1.8)  
Education    0.019  0.288   
 No education 446 (72.6) 702 (67.1) 1  1    
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 At least primary 
school 
168 (27.4) 344 (32.9) 1.3 (1.0-1.6)  1.2 (0.9-1.5)    
Marital status    0.587     
 Single, widow, 
separated/divorced 
381 (62.1) 663 (63.4) 1  -    
 Living as a couple 233 (38.0) 383 (36.6) 0.9 (0.8-1.2)  -    
Previous occupation    <0.001  0.013  0.002 
 Others 270 (44.0) 572 (54.7) 1  1  1  
 Farmer, breeder, 
fisherman 
344 (56.0) 473 (45.3) 0.6 (0.5-0.8)  0.7 (0.6-0.9)  0.7 (0.6-0.9)  
 CAR, Central African Republic; CI, Confidence Interval; OR, Odds ratio; ROC, Republic of Congo 
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Table 3. Characteristics of participants according to dementia diagnosis, EPIDEMCA, 2011-2012 
    
No dementia 
(n=1286) 
Dementia 
(n=100) p 
Age (years) 
  
<0.001 
 
65-69 528 (41.1) 13 (13.0) 
 
 
70-74 343 (26.7) 16 (16.0) 
 
 
75-79 226 (17.6) 20 (20.0) 
 
 
80+ 189 (14.7) 51 (51.0) 
 Females 713 (55.4) 80 (80.0) <0.001 
CAR 627 (48.8) 57 (57.0) 0.112 
ROC 659 (51.2) 43 (43.0)  
Rural 592 (46.0) 51 (51.0) 0.337 
No education  814 (63.3) 88 (88.9) <0.001 
missing data 0 1 
 Living as a couple 539 (41.9) 22 (22.2) <0.001 
missing data 0 1 
 Farmer, breeder, fisherman 575 (44.8) 61 (61.6) 0.001 
missing data 0 1 
 
Cognitive score (median, IQR) 
28.5 (25.4-30.4) 
19.1 (15.3-
21.9) <0.001 
T.gondii infection (positive) 815 (63.4) 64 (64.0) 0.900 
Anti-IgG titers (median, IQR) 32 (0.0-120.0) 40.5 (1.0-11.5) 0.421 
CAR: Central African Republic; IQR: interquartile range  
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Figure 1: Flow chart of study sample, EPIDEMCA, 2011-2012  
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Figure 2: Seroprevalence of Toxoplasma infection based on country and area, EPIDEMCA, 2011-
2012.  
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Figure 3: Prevalence of dementia based on quintiles of anti-Toxoplasma IgG titres (n=1,386), 
EPIDEMCA, 2011-2012. 
 
 
